Interested in the diverging communications strategies employed by Merck and Pfizer in the aftermath of public and regulatory criticism of their Cox-2 drugs? There’s a very good piece in this month’s Medical Marketing and Media.

“Merck and Pfizer bookend Big Pharma, polar opposites in personality and business strategy. They have been tested in recent months, and their responses provide a brilliant primer in crisis management � and a note of caution to competitors who have not put their crisis communications plans in order.”